Join BGV’s Rianne Ellenbroek as she speaks at the BioFIT conference on 7 – 9 December. With the highest attending rate of academics, TTOs and research institutions, BioFIT is the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences. Register here.